KA
Keyur Anilkumar Parekh
About Keyur Anilkumar Parekh
Data last updated:
Keyur Anilkumar Parekh is a Nominee Director at Sterling Biotech Limited (since 2024), Director at Zydus Vtec Limited (since 2020) and Director at Zydus Medtech Private Limited (since 2024). The companies operate in Pharma and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹972 Cr; the largest is Sterling Biotech Limited at ₹767 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Nominee Director | 29 Aug 2024 | 1985 | ₹767 Cr (FY 2025) | Active | |
| Director | 08 Sep 2020 | 2020 | ₹203 Cr (FY 2023) | Active | |
| Director | 20 Jan 2024 | 2024 | ₹2.81 Cr (FY 2025) | Active |
Board colleagues of Keyur Anilkumar Parekh
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Keyur Anilkumar Parekh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Keyur Anilkumar Parekh
Keyur Anilkumar Parekh currently holds 3 directorships: Sterling Biotech Limited (Nominee Director, since 29 Aug 2024, revenue ₹767 Cr (FY 2025)); Zydus Vtec Limited (Director, since 08 Sep 2020, revenue ₹203 Cr (FY 2023)); Zydus Medtech Private Limited (Director, since 20 Jan 2024, revenue ₹2.81 Cr (FY 2025)).
Keyur Anilkumar Parekh was first appointed on 08 Sep 2020 as Director at Zydus Vtec Limited. The most recent appointment on record is 29 Aug 2024 at Sterling Biotech Limited.
The 3 current companies of Keyur Anilkumar Parekh that report revenue have a combined latest revenue of ₹972 Cr: Sterling Biotech Limited ₹767 Cr (FY 2025); Zydus Vtec Limited ₹203 Cr (FY 2023); Zydus Medtech Private Limited ₹2.81 Cr (FY 2025).
The current boards of Keyur Anilkumar Parekh's companies include Aftab Mathur (Sterling Biotech Limited), Alok Kumar Garg (Sterling Biotech Limited), Anil Shantilal Inani (Sterling Biotech Limited), Monisha Prabhu Macedo (Sterling Biotech Limited), Neha Champaben Prajapati (Sterling Biotech Limited), Priyadarshan Kumar Singh (Sterling Biotech Limited), among others.